Batavia Biosciences to Deploy Horizon Discovery’s CHO Cell Technology to Develop Anti-Zika Biotherapeutic with Vanderbilt University Medical Center and IDBiologics

Leiden, Sept. 3 (Korea Bizwire) – Today, Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for the development of high yield antibody-expressing cell lines. Initially, Batavia will deploy the system for production of a potent Zika virus neutralizing antibody, working in collaboration with Vanderbilt [...]